Brief: Consun Pharmaceutical Says Approval For Clinical Trial Of Drug For Sk-08 Tablet
July 18 (Reuters) - Consun Pharmaceutical Group Ltd
1681.HK :
* NOTICE OF APPROVAL FOR CLINICAL TRIAL OF DRUG FOR SK-08
TABLET
* DRUG REGISTRATION APPROVAL FOR IODIXANOL INJECTION
* APPROVALS ISSUED BY NMPA OF CHINA
Further company coverage: 1681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director